Copyright
©The Author(s) 2017.
World J Gastroenterol. Mar 7, 2017; 23(9): 1594-1601
Published online Mar 7, 2017. doi: 10.3748/wjg.v23.i9.1594
Published online Mar 7, 2017. doi: 10.3748/wjg.v23.i9.1594
Figure 4 miR-1181 inhibits invasion and proliferation via STAT3 in pancreatic cancer cells.
A: Indicated cells were subjected to Western blot assay to detect STAT3 and p-STAT3 expression; B: We designed 3 siRNA targeted STAT3 and verified by PCR, aP < 0.05; C: Indicated PANC-1 cells were subjected to CCK-8 assays, cP < 0.05; D: Indicated MIA-PaCa-2 cells were subjected to CCK-8 assays, aP < 0.05; E: Indicated PANC-1 cells were subjected to transwell assays and relative migration and invasion capability was quantitative analyzed (F and G), eP < 0.001, fP < 0.001; H: Indicated MIA-PaCa-2 cells were subjected to transwell assays and relative migration and invasion capability was quantitative analyzed (I and J), eP < 0.001, fP < 0.001.
- Citation: Wang J, Guo XJ, Ding YM, Jiang JX. miR-1181 inhibits invasion and proliferation via STAT3 in pancreatic cancer. World J Gastroenterol 2017; 23(9): 1594-1601
- URL: https://www.wjgnet.com/1007-9327/full/v23/i9/1594.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i9.1594